Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

OMER Omeros Corporation
$19.28 -0.21% -0.04
Notify me if price changes either direction
Interactive Brokers Logotype

Buy OMER stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 1.4B
Enterprise value 1.6B
Trailing PE 11.678788
Forward PE 16.829695
PEG Ratio -0.049806595882353
Enterprise to EBITDA -21.691
Enterprise to revenue 40.598
Price to book MRQ -21.875839656507
Price to sales TTM 36.30532

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 38.4M
EBITDA -71913000
Diluted EPS TTM 1.65
Total Cash (MRQ) 132.0M
Current ratio (MRQ) 1.951
Operating Cash Flow (TTM) -68672000

OMER trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent OMER News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.